16-81363860-GA-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_022041.4(GAN):c.1157del(p.Lys386ArgfsTer3) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
GAN
NM_022041.4 frameshift
NM_022041.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
GAN (HGNC:4137): (gigaxonin) This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-81363860-GA-G is Pathogenic according to our data. Variant chr16-81363860-GA-G is described in ClinVar as [Pathogenic]. Clinvar id is 465385.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAN | NM_022041.4 | c.1157del | p.Lys386ArgfsTer3 | frameshift_variant | 7/11 | ENST00000648994.2 | NP_071324.1 | |
GAN | NM_001377486.1 | c.518del | p.Lys173ArgfsTer3 | frameshift_variant | 6/10 | NP_001364415.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAN | ENST00000648994.2 | c.1157del | p.Lys386ArgfsTer3 | frameshift_variant | 7/11 | NM_022041.4 | ENSP00000497351 | P1 | ||
GAN | ENST00000648349.2 | c.*865del | 3_prime_UTR_variant, NMD_transcript_variant | 6/10 | ENSP00000498114 | |||||
GAN | ENST00000650388.1 | c.*514del | 3_prime_UTR_variant, NMD_transcript_variant | 5/9 | ENSP00000498081 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Giant axonal neuropathy 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 12, 2016 | This sequence change deletes one nucleotide in exon 7 of the GAN mRNA (c.1157delA), causing a frameshift at codon 386. This creates a premature translational stop signal (p.Lys386Argfs*3) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in GAN are known to be pathogenic (PMID: 11062483). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at